Pay in 4 interest-free payments of $5.26 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The effect of GLP-1R agonists liraglutide and exendin-4 was examined in vitro on LOVO, CA-77, MCF-7, MDA-MB-231, KPL-1, MB-468, 4TI, BT483, ZR751, LNCap, PC3, ALVA-41, DU145, LNCap, PANC-1, MiaPaCa-2, PANC, CT26, SKOV3, OVCAR3, OVCAR4, A2780, and ES-2 cell lines that are expressed in several cancers including colorectal, pancreatic, thyroid, breast, prostate, ovarian, and colon (Table 1)
Are the capsules enteric-coated
The Orforglipron segment is the fastest-growing in the oral GLP-1 market due to its innovative small-molecule, non-peptide oral formulation, which eliminates the need for injections and enhances patient convenience
Vergs, M
US$ 20.49
US$ 20.35
US$ 21.12
US$ 21.86
US$ 20.12
